Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Updated aluminum pharmacokinetics following infant exposures through diet and vaccination.
Mitkus RJ, King DB, Hess MA, Forshee RA, Walderhaug MO. Mitkus RJ, et al. Vaccine. 2011 Nov 28;29(51):9538-43. doi: 10.1016/j.vaccine.2011.09.124. Epub 2011 Oct 11. Vaccine. 2011. PMID: 22001122
Pharmacokinetic modeling as an approach to assessing the safety of residual formaldehyde in infant vaccines.
Mitkus RJ, Hess MA, Schwartz SL. Mitkus RJ, et al. Vaccine. 2013 Jun 7;31(25):2738-43. doi: 10.1016/j.vaccine.2013.03.071. Epub 2013 Apr 11. Vaccine. 2013. PMID: 23583892
A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines.
Tegenge MA, Mitkus RJ. Tegenge MA, et al. Among authors: mitkus rj. J Pharmacokinet Pharmacodyn. 2013 Oct;40(5):545-56. doi: 10.1007/s10928-013-9328-y. Epub 2013 Aug 4. J Pharmacokinet Pharmacodyn. 2013. PMID: 23912214
A comparative pharmacokinetic estimate of mercury in U.S. Infants following yearly exposures to inactivated influenza vaccines containing thimerosal.
Mitkus RJ, King DB, Walderhaug MO, Forshee RA. Mitkus RJ, et al. Risk Anal. 2014 Apr;34(4):735-50. doi: 10.1111/risa.12124. Epub 2013 Oct 10. Risk Anal. 2014. PMID: 24117921
A first-generation physiologically based pharmacokinetic (PBPK) model of alpha-tocopherol in human influenza vaccine adjuvant.
Tegenge MA, Mitkus RJ. Tegenge MA, et al. Among authors: mitkus rj. Regul Toxicol Pharmacol. 2015 Apr;71(3):353-64. doi: 10.1016/j.yrtph.2015.02.005. Epub 2015 Feb 12. Regul Toxicol Pharmacol. 2015. PMID: 25683773
Pharmacokinetics and biodistribution of squalene-containing emulsion adjuvant following intramuscular injection of H5N1 influenza vaccine in mice.
Tegenge MA, Von Tungeln LS, Mitkus RJ, Anderson SA, Vanlandingham MM, Forshee RA, Beland FA. Tegenge MA, et al. Among authors: mitkus rj. Regul Toxicol Pharmacol. 2016 Nov;81:113-119. doi: 10.1016/j.yrtph.2016.08.003. Epub 2016 Aug 4. Regul Toxicol Pharmacol. 2016. PMID: 27498239
Comparative pharmacokinetic and biodistribution study of two distinct squalene-containing oil-in-water emulsion adjuvants in H5N1 influenza vaccines.
Tegenge MA, Von Tungeln LS, Anderson SA, Mitkus RJ, Vanlandingham MM, Forshee RA, Beland FA. Tegenge MA, et al. Among authors: mitkus rj. Regul Toxicol Pharmacol. 2019 Nov;108:104436. doi: 10.1016/j.yrtph.2019.104436. Epub 2019 Aug 2. Regul Toxicol Pharmacol. 2019. PMID: 31381939
Comparative physicochemical and biological characterization of NIST Interim Reference Material PM2.5 and SRM 1648 in human A549 and mouse RAW264.7 cells.
Mitkus RJ, Powell JL, Zeisler R, Squibb KS. Mitkus RJ, et al. Toxicol In Vitro. 2013 Dec;27(8):2289-98. doi: 10.1016/j.tiv.2013.09.024. Epub 2013 Oct 4. Toxicol In Vitro. 2013. PMID: 24100107
Involvement of TLR2 and TLR4 in inflammatory immune responses induced by fine and coarse ambient air particulate matter.
Shoenfelt J, Mitkus RJ, Zeisler R, Spatz RO, Powell J, Fenton MJ, Squibb KA, Medvedev AE. Shoenfelt J, et al. Among authors: mitkus rj. J Leukoc Biol. 2009 Aug;86(2):303-12. doi: 10.1189/jlb.1008587. J Leukoc Biol. 2009. PMID: 19406832 Free PMC article.
Behavioral effects of cocaine: interactions with D1 dopaminergic antagonists and agonists in mice and squirrel monkeys.
Katz JL, Kopajtic TA, Myers KA, Mitkus RJ, Chider M. Katz JL, et al. Among authors: mitkus rj. J Pharmacol Exp Ther. 1999 Oct;291(1):265-79. J Pharmacol Exp Ther. 1999. PMID: 10490913